Page 2 - ஜானி செங் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Executive Director and Chief Executive Officer
Okay, thank you. This is Christian Hogg, CEO of HUTCHMED. And today, we welcome everybody to this Fiscal Year 2020 Results and Business Update Presentation.
On the line I also have Dr. Wei-guo Su, our Chief Scientific Officer and Head of Research and Development; I have Johnny Cheng, our Chief Financial Officer; and I have Dr. Marek Kania, our Chief Medical Officer in the U.S. and Head of our International operations.
What I m planning to do today is, given this is an hour-long session, is spend about 30 minutes 25 minutes to 30 minutes on the presentation. I ll go through it relatively quickly as it s all fairly well laid out in our announcement that s just been out for an hour or so and then I ll leave the second half of the hour for Q&A and that s an opportunity for the broader team that we have here to answer any questions that you might have. ....

Johnny Cheng , Hutchison Medipharma , Chen Hong , Marek Kania , Savolutinib Exon , Christian Hogg , Head Of Research , Hutchison China Meditech Limited , Chief Executive , Fiscal Year , Business Update , Chief Scientific Officer , Chief Financial Officer , Chief Medical Officer , China Meditech , Hutchison China Meditech , Annual General Meeting , Chief Commercial Officer , Fast Track , ஜானி செங் , சென் ஹாங் , மரேக் கனியா , கிறிஸ்துவர் ஹாக் , தலை ஆஃப் ஆராய்ச்சி , ஹட்ச்சன் சீனா மேதிட்டேச் வரையறுக்கப்பட்டவை , தலைமை நிர்வாகி ,